Ningbo Menovo Pharmaceutical Co.Ltd(603538) : reply from the controlling shareholder and actual controller on the inquiry letter on abnormal fluctuation of Ningbo Menovo Pharmaceutical Co.Ltd(603538) stock trading Ningbo Menovo Pharmaceutical Co.Ltd(603538) : we have received the inquiry letter on abnormal fluctuation of Ningbo Menovo Pharmaceutical Co.Ltd(603538) stock trading sent by your company. After careful verification, the reply is as follows: the opinions of the actual controller are fully consulted. As of the date of this letter, Mr. Yao Chengzhi, the actual controller, has no major events that affect the abnormal fluctuation of the stock trading price of Ningbo Menovo Pharmaceutical Co.Ltd(603538) (hereinafter referred to as ” Ningbo Menovo Pharmaceutical Co.Ltd(603538) “), and there are no major events that should be disclosed but not disclosed, including but not limited to major asset restructuring, issuance of shares There is no abnormal stock fluctuation in major matters such as the acquisition of listed companies, debt restructuring, business restructuring, asset divestiture and asset injection. As the controlling shareholder of Ningbo Menovo Pharmaceutical Co.Ltd(603538) Ningbo Ningbo Menovo Pharmaceutical Co.Ltd(603538) Holding Group Co., Ltd., as of the date of this letter, there are no major events that affect the abnormal fluctuation of Ningbo Menovo Pharmaceutical Co.Ltd(603538) stock trading price, and there are no major events that should be disclosed but not disclosed, including but not limited to major asset restructuring, issuance of shares, acquisition of listed companies, debt restructuring, business restructuring Major events such as asset divestiture and asset injection: there is no trading of the company’s shares during abnormal stock fluctuations. We hereby reply.
© China Stock Market News